| Men have been seeking an ultimate cure for baldness | | | | under development, there are already some products |
| for thousands of years but until very recently all | | | | available on the market that seek to emulate the |
| available cures were either cosmetic cover-ups or | | | | mechanism of telomerase action but they have no |
| vitamin/mineral pills and herbal lotions, with many of | | | | scientific backing and should be avoided. Telomerase |
| them just being scams. It was only with the advent | | | | research could really change the world of medicine |
| of finasteride and minoxidil and improvements made | | | | but its commercial application might be a good |
| in hair transplantation techniques in recent years that | | | | decade away. |
| the new era began, enabling hair loss sufferers to halt | | | | Hair multiplication, often called hair cloning, is the next |
| the further progression of the balding process and | | | | hopeful treatment option being developed. This |
| replace the missing hair on top of their head using the | | | | technique involves extracting the hair follicles from |
| hair left at the back of their scalp. However, to this | | | | the back of the patient's scalp, culturing and |
| day no ultimate cure for baldness exists. | | | | multiplying them and injecting the newly-grown, hair |
| There are presently several promising drugs and new | | | | cells into the bald scalp. Among several teams of |
| techniques under development but none of these | | | | scientists on three continents researching hair |
| new therapies is expected to hit the market before | | | | multiplication, the UK healthcare firm Intercytex |
| 2010. | | | | appears to be the frontrunner. Intercytex reported |
| NEOSH101 is being developed by the US firm Neosil | | | | results of the latest stage of the clinical phase II |
| and it is currently undergoing phase IIb clinical testing. | | | | study of ICX-TRC (a suspension of a patient's own |
| NEOSH101 has been proven to be a more powerful | | | | dermal papilla cells) in March 2008 and they were |
| and faster-acting, hair growth stimulant than minoxidil | | | | largely positive. The next release is expected in |
| and it only needs applying once daily. Though | | | | September 2008. This therapy might hit the market |
| significantly improving the current hair loss treatment | | | | in 2010 at the earliest. The main benefit of hair |
| options, NEOSH101 is not going to become an | | | | multiplication would be solving the shortage of donor |
| ultimate cure for baldness. The clinical trials seem to | | | | hair that is the main limiting factor in hair |
| be advancing slower than most hair loss sufferers | | | | transplantation. |
| would like and, hence, do not hold your breath for it | | | | Generating hair follicles in hair-free skin wounds is a |
| hitting the market anytime soon. NEOSH101 is mainly | | | | completely new approach to regrowing hair. It was |
| expected to replace minoxidil and some other, less | | | | discovered accidentally as wounded skin in mice |
| powerful hair growth stimulants. | | | | started producing new hair. This technology is |
| Another promising line of development is the | | | | currently being developed by the US medical device |
| telomerase research. Telomerase is an enzyme that | | | | company, Follica, that licensed this technology from |
| is able to put natural caps on telomeres and thus | | | | the University of Pennsylvania. Though this method |
| protect them from shortening. Telomerase thereby | | | | may sound weird it only uses common instruments |
| maintains the genomic integrity. Shortened telomeres | | | | and drugs that have already been medically approved |
| are associated with the premature aging processes. | | | | and thus it might not take too long for it to become |
| However, the uncontrolled activation of telomerase | | | | available. |
| can cause cancer. Cancer research is the main focus | | | | This is the list of only a few promising treatments for |
| of the telomerase study but scientists are also | | | | baldness that are being currently developed but many |
| looking for other applications, such as anti-aging drugs | | | | others are in the pipeline. It seems that becoming |
| and drugs against baldness and grey hair. Although still | | | | bald will soon be by choice rather than destiny. |